Persson I - Search Results

1

Evaluation of post-authorization safety studies in the first cohort of EU Risk Management Plans at time of regulatory approval.

Giezen TJ, Mantel-Teeuwisse AK, Straus SM, Egberts TC, Blackburn S, Persson I, Leufkens HG. Giezen TJ, et al. Among authors: persson i. Drug Saf. 2009;32(12):1175-87. doi: 10.2165/11318980-000000000-00000. Drug Saf. 2009. PMID: 19916584

2

European Medicines Agency review of post-authorisation studies with implications for the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.

Blake KV, Prilla S, Accadebled S, Guimier M, Biscaro M, Persson I, Arlett P, Blackburn S, Fitt H. Blake KV, et al. Among authors: persson i. Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1021-9. doi: 10.1002/pds.2209. Pharmacoepidemiol Drug Saf. 2011. PMID: 22039593

3

Evaluating drug toxicity signals: is a hierarchical classification of evidence useful or a hindrance?

van Staa TP, Smeeth L, Persson I, Parkinson J, Leufkens HG. van Staa TP, et al. Among authors: persson i. Pharmacoepidemiol Drug Saf. 2008 May;17(5):475-84. doi: 10.1002/pds.1568. Pharmacoepidemiol Drug Saf. 2008. PMID: 18322905

4

What is the harm-benefit ratio of Cox-2 inhibitors?

van Staa TP, Smeeth L, Persson I, Parkinson J, Leufkens HG. van Staa TP, et al. Among authors: persson i. Int J Epidemiol. 2008 Apr;37(2):405-13. doi: 10.1093/ije/dym296. Epub 2008 Feb 8. Int J Epidemiol. 2008. PMID: 18263647

5

Increased risk of abdominal wall hernia associated with combination anti-retroviral therapy in HIV-infected patients-results from a Swedish cohort-study.

Sundström A, Mortimer O, Akerlund B, Karlsson A, Flamholc L, Håkangård C, Granholm H, Persson I, Morfeldt L. Sundström A, et al. Among authors: persson i. Pharmacoepidemiol Drug Saf. 2010 May;19(5):465-73. doi: 10.1002/pds.1922. Pharmacoepidemiol Drug Saf. 2010. PMID: 20186997

6

Hormone replacement therapy and breast cancer. A review of current knowledge.

Bergkvist L, Persson I. Bergkvist L, et al. Among authors: persson i. Drug Saf. 1996 Nov;15(5):360-70. doi: 10.2165/00002018-199615050-00006. Drug Saf. 1996. PMID: 8941497 Review.

7

Non-steroidal anti-inflammatory drugs and venous thromboembolism in women.

Bergendal A, Adami J, Bahmanyar S, Hedenmalm K, Lärfars G, Persson I, Sundström A, Kieler H. Bergendal A, et al. Among authors: persson i. Pharmacoepidemiol Drug Saf. 2013 Jun;22(6):658-66. doi: 10.1002/pds.3436. Pharmacoepidemiol Drug Saf. 2013. PMID: 23508885

8

Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes.

Bergendal A, Persson I, Odeberg J, Sundström A, Holmström M, Schulman S, Björgell O, Kieler H. Bergendal A, et al. Among authors: persson i. Obstet Gynecol. 2014 Sep;124(3):600-609. doi: 10.1097/AOG.0000000000000411. Obstet Gynecol. 2014. PMID: 25162263

9

Risk factors for venous thromboembolism in pre-and postmenopausal women.

Bergendal A, Bremme K, Hedenmalm K, Lärfars G, Odeberg J, Persson I, Sundström A, Kieler H. Bergendal A, et al. Among authors: persson i. Thromb Res. 2012 Oct;130(4):596-601. doi: 10.1016/j.thromres.2012.05.024. Epub 2012 Jun 14. Thromb Res. 2012. PMID: 22704078

10

[Birth control pills, surgery and casting leads to high risk of venous thrombosis in women. Better prophylaxis is needed for surgical procedures, as shown in case-control study].

Kieler H, Persson I, Sundström A, Hedenmalm K, Odeberg J, Bergendal A. Kieler H, et al. Among authors: persson i. Lakartidningen. 2013 Dec 4-17;110(49-50):2233-7. Lakartidningen. 2013. PMID: 24494395 Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

497 results

Search Page

Filters